Antibody profiling in quantity and avidity across SARS-CoV-2 variants identifies distinct long Covid endotypes
Frontiers in Immunology · 20.11.2026 · 17
DOI: 10.3389/fimmu.2026.1995668 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Immunology, online erschienen am 20.11.2026. Verfasst von Shivali Kohli und 6 weiteren Autor:innen. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Post-acute sequelae of SARS-CoV-2 infection or long Covid is now estimated to affect 400 million globally, but there is no diagnostic test. The patient antibody response to 15 variants of SARS-CoV-2 for both quantity and avidity was measured to test the hypothesis that antibody response signatures can define mechanistic long Covid endotypes.
Methods
A retrospective cohort analysis was performed on three cohorts: the UK control cohort (n = 46), the UK long Covid cohort (n = 113), and the US long Covid cohort (n = 90). Three measures were derived for each variant: total antibody concentration, high-quality antibody concentration, and percentage of high-quality antibody. The three parameter distributions for each variant were control median-normalised, and a top-and-tail receiver operator characteristic (ROC) analysis was performed to derive long Covid thresholds for both lower and upper extremes of the distributions.
Results
A patient was classified as having long Covid if they were above or below the extreme thresholds in one or more variants for antibody concentration, antibody quality, or percentage quality. The UK Controls vs. UK long Covid analysis gave a sensitivity of 92%, a specificity of 59%, an area under the curve (AUC) of 0.72, and a diagnostic accuracy of 81%. The ROC analysis applied to the US cohort gave a sensitivity of 90%, a specificity of 72%, an AUC of 0.88, and an accuracy of 84%.
Conclusion
The classification of patients with long Covid is 70% hypo-immune or immunocompromised, suggesting latent persistent virus; 10% are hyper-immune or autoimmune, 15% have normal antibody spectra, and 5% are hypo-immune for some variants and hyper-immune for others.
Zitieren
APA
Kohli, S., James-Pemberton, P. H., Harper, D., Watson, C. E., Bamford, R., Rees, Z. J., & Shaw, A. M. (2026). Antibody profiling in quantity and avidity across SARS-CoV-2 variants identifies distinct long Covid endotypes. Frontiers in Immunology, 17. https://doi.org/10.3389/fimmu.2026.1995668
Vancouver
Kohli S, James-Pemberton PH, Harper D, Watson CE, Bamford R, Rees ZJ, et al. Antibody profiling in quantity and avidity across SARS-CoV-2 variants identifies distinct long Covid endotypes. Frontiers in Immunology. 2026;17. doi:10.3389/fimmu.2026.1995668
BibTeX
@article{Kohli2026,
author = {Kohli, Shivali and James-Pemberton, Philip H. and Harper, Daniel and Watson, Ciara E. and Bamford, Ryan and Rees, Zachary J. and Shaw, Andrew M.},
title = {Antibody profiling in quantity and avidity across SARS-CoV-2 variants identifies distinct long Covid endotypes},
journal = {Frontiers in Immunology},
year = {2026},
volume = {17},
doi = {10.3389/fimmu.2026.1995668}
}
EUVIMED